---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-094222"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2025-07-07T23:59:59+00:00"
generated_at: "2026-05-18T09:19:23.968309+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Tivic Health appoints permanent CFO; CSO Gurfein departs; stockholders OK 425K share equity plan increase

## Summary
- Lisa Wolf appointed permanent CFO effective July 7, 2025; base salary $240,000 plus bonus up to 35% of base.
- CSO Blake Gurfein stepped down July 4, 2025, to pursue other opportunities; will consult for at least 6 months at $20,000/month.
- Gurfein receives lump sum severance of $45,938 upon signing release; no disagreement with company.
- Stockholders approved amendment to 2021 Equity Plan to increase authorized shares by 425,000 (131,428 votes for).
- Stockholders approved share issuances under Statera license, April 2025 SPA, and Mast Hill equity line.

## SEC filing metadata
- accession: 0000950170-25-094222
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2025-07-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000095017025094222/0000950170-25-094222-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000095017025094222/tivc-20250630.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-094222
- JSON: https://secwatch.observer/filing/0000950170-25-094222.json
- Plain text: https://secwatch.observer/filing/0000950170-25-094222.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.